Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
about
Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO.Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinomaTetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.Impact of smoking on the immunological profile of patients with laryngeal carcinoma.Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk.Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinomaFrequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activatedImmunology and Immunotherapy of Head and Neck CancerRole of cytokines in head and neck squamous cell carcinoma.Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections.Head and neck tumour immunology: basic concepts and new clinical implications.Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma.Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancerNatural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.Cytokine profile of breast cell lines after different radiation doses.Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.Differences in tumor stroma derived from irradiated versus non-irradiated fibroblasts in a co-culture model with head and neck squamous cell carcinoma.HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.Head and neck squamous and thyroid carcinomas: multiplexed Luminex approaches for early detection.Chronic rhinosinusitis and psoriasis: do mutually exclusive systemic Th1 and Th2 disease patterns exist?α-Tocopheryl Succinate-Based Polymeric Nanoparticles for the Treatment of Head and Neck Squamous Cell Carcinoma
P2860
Q33276933-BB7CBDCF-CAD6-4684-B48F-DB9C416CBB0BQ33834337-E3E4E57C-5A57-4127-880F-2D42DC79D605Q34068215-EF079D0E-6CA1-4D96-8EC9-2B4F8F9132A6Q34480842-8AC17F97-AD92-4A81-B83E-A23360653608Q34643517-154F5C50-99B3-40D7-885F-C17C798471CAQ35060321-7FC6BD64-81E1-4B1B-8348-AE8B630F89ABQ35644535-68B96290-5F46-4CFE-89F7-109B3F205C36Q35906771-0020781F-2693-45A7-9C41-D0ACEF4358BBQ36100837-AB2F8134-DCBD-44F5-8C52-501532AD2A98Q36613975-AF08C941-EC18-4F6C-A35E-5525F8B3C95CQ37017190-9C762FCC-62FD-4EB1-954F-863AB4246346Q37192160-305446BE-BFFC-41EC-AA6B-A88A174D1282Q37257773-D8F974B2-8158-439E-A0FF-14FF77ECD4B1Q37506015-441023D0-A71D-4913-866C-DFF2E3791212Q37590247-C2718E04-B908-4F51-B44B-896D16E23D47Q37743484-B5E2C8F9-23D3-4B40-8A5C-F6EB3CBF18D1Q38079588-7744DEF7-CDBE-4C3C-A5F5-DADC1CA7A275Q38649440-384ABD64-DD96-45F0-BEEF-92377901CA7CQ39612090-82E479E0-6D17-4DEE-82A6-01C32692B717Q41955373-C204FAA6-5D08-4599-98A3-40893CC3CC44Q42365249-235655B8-E417-4390-A76B-27863058E576Q45079934-50F3105F-9372-4041-AA69-3FA67DB6F92CQ51209028-69BFCE47-DD8B-4800-A506-F808F3B2A258Q58290775-6FCF52A0-4435-4161-8629-B6E65F90B9ACQ58716223-2A05604E-78DB-4CA6-B650-382DD02CC22B
P2860
Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@en
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@nl
type
label
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@en
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@nl
prefLabel
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@en
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@nl
P1433
P1476
Increased aberrance of cytokin ...... arcinoma of the head and neck.
@en
P2093
Deanne M R Lathers
M Rita I Young
P304
P356
10.1016/J.CYTO.2003.11.005
P577
2004-03-01T00:00:00Z